Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01XOther antineoplastic agents
- Chemical subgroupL01XA
- Chemical substanceL01XA01Cisplatin
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Brazil
Anvisa · 23 registrations
- C-PlatinBlau Farmacêutica S.A.
- CisplatinaAccord Farmacêutica Ltda
- CitoplaxLaboratorio Quimico Farmaceutico Bergamo Ltda
- FauldcisplaLibbs Farmacêutica Ltda
Canada
Health Canada · 13 registrations
At a glance
- ATC code
- L01XA01
- Registers
- 10
- Historical lists
- 2
- Registrations
- 81
- With their own page
- 37
- Companies
- 55
All medicines with Cisplatin
Human medicines from every register that match Cisplatin by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
84 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Cisplatin | United States | 10MG/VIAL, 1MG/ML, 50MG/VIAL | injectable | Marketed | HQ SPCLT Pharma |
| Cisplatina | Brazil | Authorised | Accord Farmacêutica Ltda | ||
| Cisplatin Accord | Serbia | 1mg/ml | koncentrat za rastvor za infuziju | Authorised | Evropa Lek Pharma D.O.O. Beograd |
| Cisplatin Accord | Serbia | 1mg/ml | koncentrat za rastvor za infuziju | Authorised | Evropa Lek Pharma D.O.O. Beograd |
| Cisplatin Accord | Serbia | 1mg/ml | koncentrat za rastvor za infuziju | Authorised | Evropa Lek Pharma D.O.O. Beograd |
| Cisplatin Accord | Serbia | 1mg/ml | koncentrat za rastvor za infuziju | Authorised | Evropa Lek Pharma D.O.O. Beograd |
| Cisplatin Ebewe® | Serbia | 50mg/100mL | koncentrat za rastvor za infuziju | Authorised | PredstavniŠTvo Sandoz Pharmaceuticals D.D. Beograd |
| Cisplatin Ebewe® | Serbia | 10mg/20mL | koncentrat za rastvor za infuziju | Authorised | PredstavniŠTvo Sandoz Pharmaceuticals D.D. Beograd |
| Cisplatin Injection | Canada | 1.0 MG / ML | Solution | Marketed | Teva Canada Limited |
| Cisplatin Ebewe | New Zealand | Inj 1 mg per ml, 50 ml vial | Funded | ||
| Cisplatin Ebewe | New Zealand | Inj 1 mg per ml, 100 ml vial | Funded | ||
| Cisplatin Injection | Canada | 1 MG / ML | Solution | Authorised | Omega Laboratories Limited |
| Cisplatin Injection | Canada | 1 MG / ML | Solution | Authorised | Fresenius Kabi Canada LTD |
| Cisplatin Injection | Canada | 1 MG / ML | Solution | Authorised | Strides Pharma Canada INC |
| Cisplatin Accord | New Zealand | Inj 1 mg per ml, 100 ml vial | Funded | ||
| Cisplatin Accord | New Zealand | Inj 1 mg per ml, 50 ml vial | Funded | ||
| Cisplatin Injection BP | Canada | 1 MG / ML | Solution | Marketed | Hikma Canada Limited |
| Cisplatin Injection BP | Canada | 1 MG / ML | Solution | Marketed | Pfizer Canada Ulc |
| Cisplatin Injection, BP | Canada | 1 MG / ML | Solution | Marketed | Accord Healthcare INC |
| CISPLATIN INJECTION 1 mg/ml | Singapore | 1 mg/ml | injection | Authorised | Pfizer Private Limited |
| Cisplatino Hikma 1 MG/ML Concentrado Para Solucion Para Perfusion Efg | Spain | 1 mg/ml | concentrado para solución para perfusión | Marketed | Hikma Farmaceutica (Portugal) S.A. |
| CISPLATINO ACCORD 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | Spain | 1 mg | concentrado para solución para perfusión | Marketed | Accord Healthcare S.L.U. |
| CISPLATINO PHARMACIA 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | Spain | 1 mg | concentrado para solución para perfusión | Marketed | Pharmacia Nostrum S.A. |
| Cisplatine 1 mg/ml PCH, concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Pharmachemie B.V. | |
| Cisplatine 0,5 mg/ml PCH, concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Pharmachemie B.V. |